Steven Cohen's OCUL Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 5.53 M shares of Ocular Therapeutix, Inc. (OCUL) worth $46.88 M, representing 0.06% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in OCUL, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 4.52 M shares. Largest reduction occurred in Q4 2025, reducing 3.59 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Ocular Therapeutix (OCUL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ocular Therapeutix (OCUL) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +4.52 M | Add 444.65% | 5.53 M | $8.47 |
| Q4 2025 | -3.59 M | Reduce 77.91% | 1.02 M | $12.14 |
| Q3 2025 | +2.7 M | Add 141.64% | 4.6 M | $11.69 |
| Q2 2025 | -38,148 | Reduce 1.96% | 1.9 M | $9.28 |
| Q1 2025 | -993,562 | Reduce 33.84% | 1.94 M | $7.33 |
| Q4 2024 | +895,304 | Add 43.87% | 2.94 M | $8.54 |
| Q3 2024 | -666,043 | Reduce 24.61% | 2.04 M | $8.70 |
| Q2 2024 | +2.71 M | New Buy | 2.71 M | $6.84 |
| Q4 2022 | -1,000 | Sold Out | 0 | $0.00 |
| Q3 2022 | -49,000 | Reduce 98.00% | 1,000 | $4.00 |
| Q2 2022 | +50,000 | New Buy | 50,000 | $4.02 |
Steven Cohen's Ocular Therapeutix Investment FAQs
Steven Cohen first purchased Ocular Therapeutix, Inc. (OCUL) in Q2 2022, acquiring 50,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Ocular Therapeutix, Inc. (OCUL) for 11 quarters since Q2 2022.
Steven Cohen's largest addition to Ocular Therapeutix, Inc. (OCUL) was in Q1 2026, adding 5,534,985 shares worth $46.88 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 5,534,985 shares of Ocular Therapeutix, Inc. (OCUL), valued at approximately $46.88 M.
As of the Q1 2026 filing, Ocular Therapeutix, Inc. (OCUL) represents approximately 0.06% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Ocular Therapeutix, Inc. (OCUL) was 5,534,985 shares, as reported at the end of Q1 2026.